Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,500 | 1 | 45.3% |
| Travel and Lodging | $1,287 | 3 | 38.9% |
| Food and Beverage | $489.97 | 8 | 14.8% |
| Education | $34.93 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $2,935 | 5 | $0 (2017) |
| Covidien LP | $260.55 | 2 | $0 (2019) |
| Genentech USA, Inc. | $38.66 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $25.00 | 1 | $0 (2024) |
| Mirati Therapeutics, Inc. | $21.00 | 1 | $0 (2023) |
| Novo Nordisk Inc | $18.15 | 1 | $0 (2024) |
| Acrotech Biopharma LLC | $13.93 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.15 | 2 | Novartis Pharmaceuticals Corporation ($25.00) |
| 2023 | $21.00 | 1 | Mirati Therapeutics, Inc. ($21.00) |
| 2021 | $13.93 | 1 | Acrotech Biopharma LLC ($13.93) |
| 2019 | $141.03 | 1 | Covidien LP ($141.03) |
| 2017 | $3,093 | 9 | Celgene Corporation ($2,935) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2019 | Covidien LP | LigaSure (Device) | Food and Beverage | In-kind items and services | $141.03 | General |
| Category: Vessel Sealing | ||||||
| 05/24/2017 | Celgene Corporation | Revlimid (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $586.41 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $439.56 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $261.40 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $147.61 | General |
| Category: Hematology / Oncology | ||||||
| 05/17/2017 | Covidien LP | — | Food and Beverage | In-kind items and services | $119.52 | General |
| 03/27/2017 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: BioOncology | ||||||
| 03/23/2017 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: BioOncology | ||||||
| 01/05/2017 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 2,669 | 91,321 | $697,807 | $375,072 |
| 2022 | 48 | 2,606 | 87,226 | $775,732 | $395,780 |
| 2021 | 42 | 2,470 | 84,547 | $590,176 | $309,506 |
| 2020 | 40 | 2,533 | 82,495 | $669,097 | $327,721 |
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 7 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 102 | 118 | $3,658 | $1,771 | 48.4% |
| 82746 | Folic acid level | Office | 2020 | 102 | 118 | $3,422 | $1,726 | 50.5% |
| 86300 | Immunologic analysis for detection of tumor antigen | Office | 2020 | 24 | 78 | $3,432 | $1,613 | 47.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 207 | 452 | $2,260 | $1,345 | 59.5% |
| 96374 | Injection of drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 20 | 39 | $3,120 | $1,205 | 38.6% |
| 83540 | Iron level | Office | 2020 | 103 | 163 | $2,608 | $1,049 | 40.2% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 21 | 43 | $2,537 | $1,045 | 41.2% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2020 | 69 | 130 | $1,690 | $780.76 | 46.2% |
| 96360 | Hydration infusion into a vein 31 minutes to 1 hour | Office | 2020 | 15 | 26 | $3,744 | $695.08 | 18.6% |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | Office | 2020 | 59 | 453 | $4,530 | $677.31 | 15.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2020 | 13 | 41 | $1,476 | $665.42 | 45.1% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2020 | 11 | 55 | $1,650 | $482.86 | 29.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 35 | 70 | $980.00 | $450.17 | 45.9% |
| 96361 | Hydration infusion into a vein | Office | 2020 | 15 | 41 | $2,255 | $434.28 | 19.3% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2020 | 109 | 642 | $2,568 | $325.10 | 12.7% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2020 | 35 | 70 | $560.00 | $264.32 | 47.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 50 | 2,183 | $2,183 | $215.02 | 9.8% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 22 | 66 | $330.00 | $132.60 | 40.2% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2020 | 16 | 122 | $536.80 | $124.42 | 23.2% |
| 85045 | Red blood count, automated test | Office | 2020 | 23 | 28 | $252.00 | $111.32 | 44.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 12 | 60 | $480.00 | $93.70 | 19.5% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2020 | 35 | 792 | $4,752 | $57.65 | 1.2% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 26 | 92 | $184.00 | $55.55 | 30.2% |
About Dr. Yijun Cheng, M.D
Dr. Yijun Cheng, M.D is a Hematology & Oncology healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013058213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yijun Cheng, M.D has received a total of $3,312 in payments from pharmaceutical and medical device companies, with $43.15 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($1,500).
As a Medicare-enrolled provider, Cheng has provided services to 10,278 Medicare beneficiaries, totaling 345,589 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Williamsville, NY
- Active Since 02/09/2007
- Last Updated 12/11/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013058213
Products in Payments
- Revlimid (Drug) $2,935
- LigaSure (Device) $141.03
- PLUVICTO (Drug) $25.00
- Herceptin (Biological) $24.08
- KRAZATI (Drug) $21.00
- Ozempic (Drug) $18.15
- Perjeta (Biological) $14.58
- BELEODAQ (Drug) $13.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Williamsville
Michael Krabak, Md, MD
Hematology & Oncology — Payments: $40,158
Dr. Saifuddin Soniwala, M.d, M.D
Hematology & Oncology — Payments: $22,854
Hong Liu, Md Phd, MD PHD
Hematology & Oncology — Payments: $10,708
Dr. Robert Setlik, M.d.,Ph.d, M.D.,PH.D
Hematology & Oncology — Payments: $5,055
Frederick Hong, Md, MD
Hematology & Oncology — Payments: $1,741
Dr. Robert Zielinski, Md, MD
Hematology & Oncology — Payments: $289.06